Lexaria Bioscience (LEXX) Updates its Ongoing Human Study GLP-1-H24-4

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ENPH
2. HOOD
3. NXPI
4. BA
5. STX
6. V
7. CSGP
8. LSTR
9. UPS
10. KIDS

Go back to Lexaria Bioscience (LEXX) Updates its Ongoing Human Study GLP-1-H24-4

Lexaria Updates its Ongoing Human Study GLP-1-H24-4

April 3, 2025 9:14 AM EDT

Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss

KELOWNA, BC / ACCESS Newswire / April 3, 2025 / Lexaria Bioscience Corp. (NASDAQ: LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to provide this progress update on its Phase 1b, 12-week chronic study... More